AIRDOC-B (02251) recommends appointing Wu Haoran as an independent non-executive director.
Eagle Eye Technology-B (02251) has announced that at the meeting held on September 20, 2024, the board of directors decided...
AIRDOC-B (02251) Announcement: At the meeting held on September 20, 2024, the board of directors decided (i) to propose the appointment of Mr. Wu Haoran as an independent non-executive director of the second board of directors at the upcoming special shareholders' meeting for shareholders' consideration and approval, and (ii) to appoint Mr. Wu as the chairman of the audit committee and a member of the remuneration and assessment committee and the strategic committee (subject to Mr. Wu's appointment as an independent non-executive director being approved by shareholders). The appointment of Mr. Wu as the chairman of the audit committee, a member of the remuneration and assessment committee, and the strategic committee will take effect after being approved by shareholders at the special shareholders' meeting for his appointment as an independent non-executive director.
Related Articles

SIMCERE PHARMA(02096): Enze Shu has been approved by the National Medical Products Administration to be launched in China.

SIRNAOMICS-B (02257): Ouyang Yunlong appointed as non-executive director.

On July 2, MNSO (09896) spent $231,100 to repurchase 51,200 shares.
SIMCERE PHARMA(02096): Enze Shu has been approved by the National Medical Products Administration to be launched in China.

SIRNAOMICS-B (02257): Ouyang Yunlong appointed as non-executive director.

On July 2, MNSO (09896) spent $231,100 to repurchase 51,200 shares.

RECOMMEND

U.S. Senate Passes “Big and Beautiful” Bill, Triggering Surge in Gold Amid Soaring Deficit Concerns
02/07/2025

Declining Demand Triggers Price Drop; Photovoltaic Glass Industry May Be Preparing for a New Round of Coordinated Production Cuts
02/07/2025

Surge in Prices of Chinese-Made Goods Highlights Tariff Impact on U.S. Consumers
02/07/2025